Medicare Enrolled
Dr. Faizuddin Khaja, MD
Ophthalmology · Cincinnati, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khaja from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khaja?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khaja
Dr. Faizuddin Khaja is an ophthalmology specialist in Cincinnati, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Khaja performed 17,293 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khaja received a total of $4,481 from 31 pharmaceutical and/or device companies across 158 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khaja is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 5% volume in OH
$4,481 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗17,293
Medicare services
Top 5% in OH for ophthalmology
Not available
Unique patients (not deduplicated)
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
9,180 | $29 | $108 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
2,092 | $29 | $100 |
| Aflibercept eye injection (Eylea) | 1,780 | $685 | $1,850 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
1,462 | $89 | $534 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
616 | $52 | $134 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
571 | $90 | $165 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
287 | $159 | $472 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
267 | $80 | $190 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
201 | $64 | $115 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
157 | $27 | $120 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
106 | $47 | $80 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
100 | $1 | $10 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
98 | $10 | $25 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
86 | $413 | $1,400 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
73 | $115 | $230 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
50 | $98 | $175 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
33 | $35 | $140 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
32 | $18 | $50 |
| Ultrasound scan to determine eye length and lens power An ultrasound procedure used to measure the length of the eye and calculate the power of the lens. |
28 | $44 | $105 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $132 | $225 |
| New patient office visit, complex (60-74 min) | 21 | $146 | $295 |
| Injection into eye membrane A procedure involving the injection of a drug or substance into the membrane that covers the eyeball. |
18 | $44 | $174 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
12 | $232 | $466 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
86.7% medium
12.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,481
Total received (2018-2024)
Avg $640/year across 7 years
Top 19% in OH for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
158
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,589
2023
$901
2022
$208
2021
$452
2020
$167
2019
$619
2018
$546
Payments by company (2024)
Regeneron Healthcare Solutions, Inc.
$464
Johnson & Johnson Surgical Vision, Inc.
$328
Genentech USA, Inc.
$159
Apellis Pharmaceuticals, Inc.
$145
Astellas Pharma US Inc
$123
RxSight Inc
$103
Alimera Sciences, Inc.
$85
ABBVIE INC.
$73
Alcon Vision LLC
$38
Mallinckrodt Hospital Products Inc.
$26
Biogen, Inc.
$15
Amgen Inc.
$15
Halozyme Inc
$13
Top 3 companies account for 59.9% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$1,025
Alimera Sciences, Inc.
$625
Johnson & Johnson Surgical Vision, Inc.
$385
Genentech USA, Inc.
$330
Allergan Inc.
$265
Astellas Pharma US Inc
$229
Apellis Pharmaceuticals, Inc.
$189
ABBVIE INC.
$183
Halozyme Inc
$155
Aerie Pharmaceuticals, Inc.
$118
Novartis Pharmaceuticals Corporation
$107
RxSight Inc
$103
Biogen, Inc.
$101
Bausch & Lomb, a division of Bausch Health US, LLC
$99
OPTOS, INC.
$97
EyePoint Pharmaceuticals US, Inc.
$85
Alcon Vision LLC
$63
Allergan, Inc.
$61
Bausch & Lomb Americas Inc.
$37
Glaukos Corporation
$27
Mallinckrodt Hospital Products Inc.
$26
Spark Therapeutics, Inc.
$26
Coherus Biosciences Inc.
$24
Carl Zeiss Meditec, Inc.
$22
Mallinckrodt Enterprises LLC
$18
Sun Pharmaceutical Industries Inc.
$15
Omeros Corporation
$15
Amgen Inc.
$15
Shire North American Group Inc
$13
Ocular Therapeutix, Inc.
$12
Vyera Pharmaceuticals, LLC
$11
Top 3 companies account for 45.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ARGOS · BYOOVIZ · BromSite (bromfenac ophthalmic solution) 0.075% · CIRRUS HD-OCT · Centurion · Cimerli · Clareon · DEXTENZA · DEXYCU · Daraprim Tablet 25mg · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · HYLENEX RECOMBINANT · Hylenex · ILUVIEN · Iluvien · Izervay · LUXTURNA · Lucentis · Monaco · OZURDEX · Omidria · RXSIGHT CONTACT LENS · Rhopressa · Syfovre · TECNIS IOL · TEPEZZA · VABYSMO · VERITAS Vision System · VYZULTA · Vabysmo · XIIDRA · XIPERE · YUTIQ · iStent Trabecular Micro-Bypass Stent System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
148
County median income
$70,816
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY OF CINCINNATI MEDICAL CENTER, LLC
1.4 mi
1.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khaja is a mixed practice specialist, with above-average Medicare volume (top 5% in OH), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khaja experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Khaja performed 9,180 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khaja receive payments from pharmaceutical companies?
Yes. Dr. Khaja received a total of $4,481 from 31 companies across 158 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khaja's costs compare to other ophthalmologists in Cincinnati?
Dr. Khaja's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khaja) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Cincinnati
Browse ophthalmologists in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in OH
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in OH
Which OH ophthalmologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Alimera Sciences, Inc. Payments to Doctors
See all physicians who received payments from Alimera Sciences, Inc.
By company
Johnson & Johnson Surgical Vision, Inc. Payments to Doctors
See all physicians who received payments from Johnson & Johnson Surgical Vision, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology